You are here: Industry Insights > Sanofi

News List

Clinical programme to evaluate Kevzara® as COVID-19 treatment begins europeanpharmaceuticalreview
March 19, 2020
Led by Sanofi and Regeneron, clinical trials to examine Kevzara (sarilumab) as an effective COVID-19 treatment will begin in the US.
Sanofi and Regeneron trial Kevzara to treat severe Covid-19 pharmaceutical-technology
March 17, 2020
Sanofi and Regeneron Pharmaceuticals have initiated a clinical programme of rheumatoid arthritis drug Kevzara (sarilumab) to treat hospitalised patients with severe Covid-19 coronavirus infection.
Sanofi and Regeneron to assess Kevzara to treat Covid-19 pharmaceutical-technology
March 12, 2020
Sanofi and Regeneron Pharmaceuticals have plans to initiate clinical trials of rheumatoid arthritis drug Kevzara for the treatment of Covid-19 symptoms.
Sanofi, Babylon link-up to tackle digestive health pharmatimes
March 06, 2020
Sanofi has teamed up with video consultation business Babylon, in order to offer an online AI Health Service for those who suffer from digestive health issues.
Sanofi to pay $11.9-mn to resolve US drug charity kickback probe expresspharma
March 03, 2020
The deal, announced by the US Justice Department, was the latest to result from an industry-wide probe of drugmakers' financial support of patient assistance charities that has resulted in more than $865 million in settlements.
Nurix Therapeutics, Sanofi Announce Development Collaboration americanpharmaceuticalreview
January 15, 2020
Nurix Therapeutics announced a global strategic collaboration with Sanofi to discover, develop and commercialize a pipeline of targeted protein degradation drugs for patients with challenging diseases in multiple therapeutic areas.
Regeneron to lay off field staffers as it restructures Sanofi partnership fiercepharma
January 03, 2020
With its long-standing partnership with Sanofi in its final days, Regeneron is in a belt-tightening phase as it prepares for its new reality.
Sanofi Awarded $226 Million by HHS to Expand Pandemic Influenza Preparedness americanpharmaceuticalreview
December 17, 2019
Sanofi Pasteur has entered into an agreement with the U.S. Department of Health and Human Services (HHS) to increase the company's domestic pandemic influenza vaccine production ...
Sanofi announces it will acquire Synthorx for $2.5 billion europeanpharmaceuticalreview
December 16, 2019
Sanofi has announced it is to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 billion.
Sanofi ends research in diabetes, narrows units to spur profit expresspharma
December 12, 2019
Sanofi SA said recently that it would end its research efforts in diabetes and cardiovascular diseases as part of a revamp that will narrow the number of its business units in the hope of bolstering growth and profit.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 43 44 Next page